VeriSign Gets Dual Analyst Upgrades, Both Targets Above $367
Wedbush raised its VeriSign price target to $367 while Baird moved to $380 in the same 48-hour window, collectively flagging 16-21% upside as the domain registry monopoly generates $800mn in annual fr
VeriSign Gets Dual Analyst Upgrades, Both Targets Above $367
NEW YORK, November 3 —
VeriSign, Inc. (VRSN) collected back-to-back analyst upgrades to $367 and $380 in 48 hours while trading 16% below the lower target at $315.
- Wedbush raised price target to $367 from $351 (+$16, +4.6%), Outperform maintained; Baird separately moved to $380 from $355 in the same 48-hour window
- At $315, VRSN trades at 28.7x forward P/E against $800mn in trailing FCF on $1.7bn revenue, a 47% FCF margin that most software companies cannot approach
- Domain base renewal rate and Q3 2026 earnings are the next print that validates or resets both targets
Baird's $380 Sets the Street Ceiling, for Now
The signal is not either target in isolation but their simultaneous arrival. Wedbush moved first, adding $16 to reach that target with Outperform maintained. Baird followed within hours, lifting by $25 to $380. Street consensus rarely tightens around a name in a single trading session without a catalyst, which here is either VRSN's upcoming earnings setup or an incremental read on domain registry renewal trends.
With the stock at $315, both calls imply 16-21% appreciation before either desk revisits its thesis. That spread between price and target typically closes on earnings, not headlines.
47% Free Cash Flow Margin Is the Moat, Not the Revenue Line
VeriSign, Inc. (VRSN) grew TTM revenue 5.7% YoY to $1.7bn. Modest, by any growth screen. The case for both analysts lives in what the company does with that revenue: $800mn in FCF, a margin approaching 47%, on a business with a structural ceiling on costs.
There is no R&D arms race, no distribution overhead, no customer acquisition spend at scale. VRSN holds the exclusive registry agreement for .com and .net domains. When renewals hold, so does the cash generation. That is what Wedbush and Baird are pricing, not the growth rate.
One Insider Sold $1mn. The Company Generated $800mn.
A recent SEC filing shows an insider sale worth $1,002,100. In isolation, a yellow flag. In context, it represents roughly 0.1% of trailing FCF. The signal is proportionally small and consistent with routine executive liquidity planning rather than a directional read on the earnings outlook.
Insider sales at toll-road businesses with monopoly economics read differently than insider sales at cash-burning growth names. VRSN is the former. Funding risk and dilution are not the operative concern here.
The Renewal Rate Is the One Number That Breaks Both Targets
Both analyst calls rest on renewal rate stability. VRSN's domain base is a recurring revenue stream, and any deterioration in renewal rates cuts through the FCF math faster than any macro input. Q3 2026 earnings and the accompanying domain count update are the next checkpoints. If renewal rates slip below recent trends, the target band reopens on the downside immediately. Investors stress-testing assumptions can model different renewal rate scenarios against that FCF baseline using the DCF calculator.
Until then, the convergence of two independent desks in the same 48-hour window raises the cost of being short this name into the print.
For a full breakdown of VRSN's valuation metrics, earnings history, and analyst coverage, visit the VRSN stock intelligence page.
Basis Report is independent research for informational purposes. It is not investment advice and not a recommendation to buy or sell any security.
Wedbush raised its price target on VeriSign to $367 from $351, maintaining an Outperform rating.